IBUPROFEN AND FAMOTIDINE

IBUPROFEN AND FAMOTIDINE was reported 11 times

IBUPROFEN AND FAMOTIDINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CEREBELLAR TONSILLAR ECTOPIA 1 0.1429
1 DERMATOPATHIC LYMPHADENOPATHY 1 0.0417
2 AVIAN INFLUENZA 1 0.0156
3 MUSCLE OEDEMA 1 0.0046
4 SYRINGOMYELIA 1 0.0036
5 BURSA DISORDER 1 0.0034
6 LEIOMYOMA 1 0.0014
7 DACTYLITIS 1 0.0010
8 H1N1 INFLUENZA 1 0.0007
9 ENTHESOPATHY 1 0.0006
10 MYELOPATHY 1 0.0005
11 EYELID DISORDER 1 0.0004
12 CARTILAGE INJURY 1 0.0004
13 PLATELET DISORDER 1 0.0004
14 RADICULOPATHY 1 0.0004
15 OXYGEN SATURATION ABNORMAL 1 0.0004
16 DYSCHEZIA 1 0.0003
17 DEAFNESS NEUROSENSORY 1 0.0003
18 PHYSICAL DISABILITY 1 0.0002
19 BLOOD CHOLESTEROL ABNORMAL 1 0.0002
20 UMBILICAL HERNIA 1 0.0002
21 CONCOMITANT DISEASE AGGRAVATED 1 0.0002
22 LARGE INTESTINE PERFORATION 1 0.0001
23 DIVERTICULUM 1 0.0001
24 LOW DENSITY LIPOPROTEIN INCREASED 1 0.0001
25 NICOTINE DEPENDENCE 1 0.0001
26 PRODUCT ADMINISTRATION INTERRUPTED 1 0.0001
27 RHINITIS 1 0.0001
28 RESPIRATORY SYNCYTIAL VIRUS INFECTION 1 0.0001
29 SPINAL OSTEOARTHRITIS 1 0.0001
30 INITIAL INSOMNIA 1 0.0001
31 EAR DISCOMFORT 1 0.0001
32 ROTATOR CUFF SYNDROME 1 0.0001
33 PROCEDURAL PAIN 2 0.0001
34 IMPAIRED QUALITY OF LIFE 1 0.0001
35 ECONOMIC PROBLEM 1 0.0001
36 TENDONITIS 1 0.0001
37 PNEUMOTHORAX 1 0.0001
38 OBESITY 1 0.0001
39 SCIATICA 1 0.0001
40 BACK DISORDER 1 0.0001
41 HEAD DISCOMFORT 1 0.0001
42 RESTLESS LEGS SYNDROME 1 0.0001
43 GASTRIC ULCER 1 0.0001
44 ORAL HERPES 1 0.0001
45 BLOOD PRESSURE ABNORMAL 1 0.0001
46 OSTEOARTHRITIS 2 0.0000
47 NEURALGIA 1 0.0000
48 ABDOMINAL PAIN LOWER 1 0.0000
49 JOINT STIFFNESS 1 0.0000
50 EAR INFECTION 1 0.0000
51 INTENTIONAL DOSE OMISSION 1 0.0000
52 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
53 WHEEZING 2 0.0000
54 LACRIMATION INCREASED 1 0.0000
55 NIGHT SWEATS 1 0.0000
56 EXPIRED PRODUCT ADMINISTERED 1 0.0000
57 EYE PRURITUS 1 0.0000
58 C-REACTIVE PROTEIN INCREASED 1 0.0000
59 RESTLESSNESS 1 0.0000
60 COLITIS 1 0.0000
61 PSORIATIC ARTHROPATHY 1 0.0000
62 RECTAL HAEMORRHAGE 1 0.0000
63 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
64 TINNITUS 1 0.0000
65 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
66 LUNG DISORDER 1 0.0000
67 DRY EYE 1 0.0000
68 ABDOMINAL DISTENSION 2 0.0000
69 EYE PAIN 1 0.0000
70 NASAL CONGESTION 1 0.0000
71 VERTIGO 1 0.0000
72 DISCOMFORT 1 0.0000
73 BLOOD CREATININE INCREASED 1 0.0000
74 INJURY 1 0.0000
75 SLEEP DISORDER 1 0.0000
76 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
77 DYSGEUSIA 1 0.0000
78 HOT FLUSH 1 0.0000
79 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
80 INTENTIONAL PRODUCT MISUSE 1 0.0000
81 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
82 ALOPECIA 2 0.0000
83 JOINT SWELLING 1 0.0000
84 EMOTIONAL DISTRESS 1 0.0000
85 PSORIASIS 1 0.0000
86 DEHYDRATION 1 0.0000
87 PRODUCT QUALITY ISSUE 1 0.0000
88 VISION BLURRED 1 0.0000
89 ARTHRALGIA 3 0.0000
90 HOSPITALISATION 1 0.0000
91 PARAESTHESIA 1 0.0000
92 URTICARIA 1 0.0000
93 ABDOMINAL DISCOMFORT 1 0.0000
94 MYALGIA 1 0.0000
95 URINARY TRACT INFECTION 1 0.0000
96 COVID-19 1 0.0000
97 MUSCLE SPASMS 1 0.0000
98 NASOPHARYNGITIS 1 0.0000
99 PAIN 3 0.0000
100 ABDOMINAL PAIN UPPER 1 0.0000
101 HYPERTENSION 1 0.0000
102 RASH 2 0.0000
103 CONSTIPATION 1 0.0000
104 BACK PAIN 1 0.0000
105 PRODUCT USE IN UNAPPROVED INDICATION 1 0.0000
106 WEIGHT DECREASED 1 0.0000
107 COUGH 1 0.0000
108 ANXIETY 1 0.0000
109 PAIN IN EXTREMITY 1 0.0000
110 PRURITUS 1 0.0000
111 DIZZINESS 1 0.0000
112 DYSPNOEA 1 0.0000
113 HEADACHE 1 0.0000
114 DIARRHOEA 1 0.0000
115 DRUG INEFFECTIVE 2 0.0000
116 FATIGUE 1 0.0000
117 NAUSEA 1 0.0000
118 DEATH 1 0.0000